Hi Pete! The buzz was around another company. Definitely more neurologists there than people in oncology - though there was a good number of people from oncology. So neuro won out and the company buzz fit that. Later I found out that MGH neurosurgery dept. had just signed on to be a clinical trial site for the company that was being talked about - so that explains the buzz. Of little ctix I heard not a whisper - but that's ok. There is so much research going on in that system that its very unusual to hear about specific early trials.